Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0001209191-23-056981

Chief Financial Officer gave up 20,153 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Amello Jason Chief Financial Officer 2023-11-28 Shares withheld for taxes −20,153 $0.90 $18,138 202,009 D
Loading xslF345X05/doc4.xml…